Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_provenance.
- NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_provenance.
- NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_assertion evidence source_evidence_literature NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_provenance.
- NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_assertion SIO_000772 18496131 NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_provenance.
- NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_assertion wasDerivedFrom gad-20150221 NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_provenance.
- NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_assertion wasGeneratedBy ECO_0000203 NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_provenance.
- gad-20150221 importedOn "2015-02-21" NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_provenance.